.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Breez has shown a stable performance in the California market, particularly in the Capsules category, where it maintained a consistent rank of 2nd place from June to September 2025. Despite a decline in sales from $811,320 in June to $662,956 in September, the brand's stronghold in this category remains unchallenged. In contrast, Breez's presence in the Edible category in California is less prominent, with rankings hovering in the mid-40s, indicating a weaker competitive position. Interestingly, Breez's performance in Tincture & Sublinguals saw some improvement from June to July, rising from 18th to 17th, but the absence of ranking data for August and September suggests they fell out of the top 30, which could be a cause for concern.
In Illinois, Breez exhibits a robust presence in the Capsules category, consistently holding the 4th position throughout the observed months. However, the brand's sales in this category have shown a downward trend, decreasing from $33,641 in June to $29,244 in September. The Edible category presents a mixed picture, with Breez ranking 55th in June and improving to 50th in July, but lacking data for subsequent months, which may imply they did not sustain their top 30 status. Additionally, Breez's Vapor Pens category ranking fluctuated outside the top 50, with a slight improvement from 68th in August to 66th in September, indicating potential growth or stabilization in this segment.
Competitive Landscape
In the competitive landscape of the California cannabis capsules market, Breez consistently holds the second rank from June to September 2025, showcasing a stable position amidst fluctuating sales. Despite a gradual decline in sales over these months, Breez maintains its rank, indicating strong brand loyalty or market presence. The top competitor, Level, consistently ranks first, with sales figures significantly higher than Breez, suggesting a dominant market position. Meanwhile, ABX / AbsoluteXtracts and Kikoko remain in third and fourth positions respectively, with sales figures lower than Breez, reinforcing Breez's competitive edge in the market. This consistent ranking amidst declining sales indicates that while Breez is a strong player, there is room for growth and potential strategies to capture more market share from its competitors.
Notable Products
In September 2025, the top-performing product for Breez was the Hybrid Extra-Strength Tablet 50-Pack (1000mg) in the Capsules category, maintaining its number one rank consistently from previous months with sales of 4284 units. Following closely, the Indica Extra Strength Tablet 50-Pack (1000mg) held the second rank, also unchanged from prior months. The Sativa Extra Strength Tablet 50-Pack (1000mg) remained in third place, showing a slight increase in sales compared to August. Notably, the CBD/THC/CBN 2:1:1 Nighttime Extra Strength Tablets 50-Pack (500mg CBD, 250mg THC, 250mg CBN) rose to the fourth rank, marking its first appearance in the list since July. The Sativa Extra Strength Tablets 5-Pack (100mg) debuted in the rankings at fifth place, indicating a new entry for September.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
